findmyKOL
Clinical trialNCT01317927CompletedPhase 1Interventional

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

SponsorSpectrum Pharmaceuticals, IncEnrollment27Hematological MalignancySolid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Sunil Sharma, MD, FACP

    Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, UT 84112

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Huntsman Cancer Center, University of Utah

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2010
Primary completion
30 Jun 2015
Completion
30 Jun 2015
Last update posted
23 Sept 2015
Registered enrollment
27
Registry id
NCT01317927

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.